The activation of Atrogin-1 and MuRF-1 is the common key regulatory step contributing to the protein degradation in atrophying muscle (55, 56), whereas the imbalance between protein synthesis and degradation is a crucial cause of muscle mass loss in sarcopenia (57). This evidence concerns the gene FBXO32 and sarcopenia.